Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Novel Compound for Alcoholism Treatment: a Translational Strategy - Part II

Trial Profile

A Novel Compound for Alcoholism Treatment: a Translational Strategy - Part II

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2018

At a glance

  • Drugs PF 5190457 (Primary)
  • Indications Alcoholism
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2018 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.
    • 06 Jul 2018 New trial record
    • 28 Jun 2018 According to the University of Rhode Island media release, Akhlaghi is the co-principal investigator of this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top